Nutrients Webinar | Role of Fatty Acids in Metabolic Dysfunction—Associated Fatty Liver Disease (MAFLD) and Concomitant Cardiovascular Risk, 13 July 2023
Welcome message by Dr. Alexander V. Sorokin, the webinar Chair:
Cardiometabolic disorders represent a significant public health concern and they put millions of people worldwide at a higher risk of developing heart disease and type 2 diabetes and come with associated healthcare expenses. Among the established risk factors comprising cardiometabolic disorders, such as abdominal obesity, insulin resistance and hypertension, non-alcoholic fatty liver disease (NAFLD) has been of particular clinical interest. Moreover, accompanying dyslipidemia, elevated triglycerides and impaired resolution of inflammation have compelled international experts to revise the current understanding of NAFLD and propose a new definition which more accurately represents the pathophysiological mechanisms behind NAFLD and cardiometabolic complications. Thus, the term metabolic dysfunction-associated fatty liver disease (MAFLD) has been coined. With the recent progress in fatty acids research and clinical application of n–3 fatty acids, this seminar aims to summarize the current knowledge and increase awareness among healthcare providers.
Date: 13 July 2023 at 4:00 p.m. CEST | 10:00 a.m. EDT | 10:00 p.m. CST Asia
Register now for free!
Program:
|
Speaker/Presentation |
Time in CEST |
Time in EDT |
|
Dr. Alexander V. Sorokin |
4:00–4:10 p.m. |
10:00–10:10 a.m. |
|
Dr. You Zhou |
4:10–4:30 p.m. |
10:10–10:30 a.m. |
|
Dr. Trisha Jean Grevengoed |
4:30–4:50 p.m. |
10:30–10:50 a.m. |
|
Q&A Session |
4:50–5:05 p.m. |
10:50–11:05 a.m. |
|
Dr. Alexander Sorokin |
5:05–5:10 p.m. |
11:05–11:10 a.m. |
After registering, you will receive a confirmation email containing information on how to join the webinar. Registrations with academic institutional email addresses will be prioritized.
Unable to attend? Register anyway to be notified when the recording is available to watch.
Webinar Chair and Keynote Speakers:
- Dr. Alexander V. Sorokin, Section of Inflammation and Cardiometabolic Disease, Cardiovascular Branch, National Heart, Lung and Blood Institute (NHLBI), National Institutes of Health (NIH), Bethesda, MD 20892-1666, USA;
- You Zhou, Division of Infection & Immunity, School of Medicine, Cardiff University, UK;
- Trisha Jean Grevengoed, Endocrinology and Metabolism, Faculty of Health and Medical Sciences, 1958 Frederiksberg C, Denmark.
Relevant Special Issue:
“Biological and Clinical Implication of Fatty Acids in Liver and Cardiometabolic Disorders”
Edited by: Dr. Alexander V. Sorokin